CA2392740A1 - Il-6 like polynucleotides, polypeptides, and antibodies - Google Patents

Il-6 like polynucleotides, polypeptides, and antibodies Download PDF

Info

Publication number
CA2392740A1
CA2392740A1 CA002392740A CA2392740A CA2392740A1 CA 2392740 A1 CA2392740 A1 CA 2392740A1 CA 002392740 A CA002392740 A CA 002392740A CA 2392740 A CA2392740 A CA 2392740A CA 2392740 A1 CA2392740 A1 CA 2392740A1
Authority
CA
Canada
Prior art keywords
polypeptide
sequence
polypeptides
antibody
polynucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002392740A
Other languages
English (en)
French (fr)
Inventor
Steven M. Ruben
Yang-Gu Shi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2392740A1 publication Critical patent/CA2392740A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5412—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • AIDS & HIV (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002392740A 1999-12-09 2000-12-07 Il-6 like polynucleotides, polypeptides, and antibodies Abandoned CA2392740A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16983899P 1999-12-09 1999-12-09
US60/169,838 1999-12-09
PCT/US2000/033134 WO2001042484A1 (en) 1999-12-09 2000-12-07 Il-6 like polynucleotide

Publications (1)

Publication Number Publication Date
CA2392740A1 true CA2392740A1 (en) 2001-06-14

Family

ID=22617397

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002392740A Abandoned CA2392740A1 (en) 1999-12-09 2000-12-07 Il-6 like polynucleotides, polypeptides, and antibodies

Country Status (6)

Country Link
US (1) US20020037523A1 (https=)
EP (1) EP1244807A1 (https=)
JP (1) JP2004500810A (https=)
AU (1) AU2066301A (https=)
CA (1) CA2392740A1 (https=)
WO (1) WO2001042484A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4007477B2 (ja) * 2000-10-13 2007-11-14 独立行政法人科学技術振興機構 エピトープの免疫原性が増強された人工タンパク質
JP2006516635A (ja) * 2003-01-30 2006-07-06 メディミューン，インコーポレーテッド インテグリンαｖβ３アンタゴニストの使用
KR101193708B1 (ko) * 2003-10-17 2012-10-22 추가이 세이야쿠 가부시키가이샤 중피종 치료제
IL163856A0 (en) * 2004-09-01 2005-12-18 Applied Research Systems Use of IL-6 in vascular complications
PT2485583T (pt) 2009-10-06 2016-09-22 Univ Yale Ratinhos geneticamente modificados e enxerto
MX350385B (es) 2011-02-15 2017-09-04 Regeneron Pharma Ratones de m-csf humanizada.
IN2015DN02032A (https=) 2012-09-07 2015-08-14 Univ Yale
CA2887706C (en) 2012-11-05 2022-08-02 Regeneron Pharmaceuticals Genetically modified non-human animals and methods of use thereof
SG10202002187WA (en) 2014-05-19 2020-04-29 Regeneron Pharma Genetically modified non-human animals expressing human epo
KR102658190B1 (ko) 2015-04-13 2024-04-17 리제너론 파마슈티칼스 인코포레이티드 인간화된 sirpa-il15 녹인 마우스 및 이의 이용 방법
KR102618843B1 (ko) 2016-09-20 2024-01-02 베링거잉겔하임베트메디카게엠베하 신규한 ehv 삽입 부위 orf70

Also Published As

Publication number Publication date
EP1244807A1 (en) 2002-10-02
JP2004500810A (ja) 2004-01-15
AU2066301A (en) 2001-06-18
US20020037523A1 (en) 2002-03-28
WO2001042484A1 (en) 2001-06-14

Similar Documents

Publication Publication Date Title
EP1233983A2 (en) Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies
CA2398255A1 (en) Bcl-2-like polynucleotides, polypeptides, and antibodies
EP1227833A1 (en) Plasminogen-like polynucleotides, polypeptides, and antibodies
CA2403508A1 (en) Extracellular matrix polynucleotides, polypeptides, and antibodies
WO2001012786A1 (en) Retinoid receptor interacting polynucleotides, polypeptides, and antibodies
CA2381451A1 (en) Attractin-like polynucleotides, polypeptides, and antibodies
EP1345567A2 (en) Calcium channel transport polynucleotides, polypeptides, and antibodies
CA2392740A1 (en) Il-6 like polynucleotides, polypeptides, and antibodies
CA2364471A1 (en) Human serpin proteins
CA2399913A1 (en) Adam polynucleotides, polypeptides, and antibodies
CA2365917A1 (en) Bone morphogenic proteins
US20030050466A1 (en) TM4SF polynucleotides, polypeptides, and antibodies
CA2399921A1 (en) Protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies
CA2392693A1 (en) Four disulfide core domain-containing (fdcd) polynucleotides, polypeptides, and antibodies
EP1212407A1 (en) Immunoglobulin superfamily polynucleotides, polypeptides, and antibodies
CA2392717A1 (en) Cytokine receptor-like polynucleotides, polypeptides, and antibodies
CA2395054A1 (en) Human polynucleotides, polypeptides, and antibodies
CA2389330A1 (en) Kringle domain-containing polynucleotides, polypeptides, and antibodies
CA2378929A1 (en) Serine proteases
CA2384841A1 (en) Death domain-containing receptor polynucleotides, polypeptides, and antibodies
WO2001037857A1 (en) Major intrinsic protein (mip)-like polynucleotides, polypeptides, and antibodies
WO2001018049A1 (en) Steroid hormone receptor polynucleotides, polypeptides, and antibodies

Legal Events

Date Code Title Description
FZDE Discontinued